指南与共识妇科肿瘤

卵巢癌临床研究:妇科癌症协作组的共识推荐

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
指南 / 共识 · Lancet Oncol · 2022-01-01

妇科癌症协作组(GCIG)于2021年10月以线上形式召开第六届卵巢癌临床研究会议,33个成员组参与制定20条关于一线治疗、复发疾病、疾病亚组和未来试验的共识声明,其中14条获一致共识,其余6条一致性超过90%。

要点

  • 33个GCIG成员组参与制定20条卵巢癌临床研究共识声明,覆盖一线治疗、复发、亚组和未来试验。
  • 14条声明获一致共识,其余6条一致性超过90%。
  • 共识旨在协调国际卵巢癌临床试验设计要素并明确未满足需求。

核心结论

  • GCIG卵巢癌临床研究共识会议达成20条声明,14条获一致共识,其余6条一致性超过90%,旨在促进国际临床研究协调。

研究设计与样本

  • GCIG第六届卵巢癌临床研究会议于2021年10月以线上形式召开,所有33个GCIG成员组参与制定、完善和采纳20条声明,分为一线治疗、复发疾病、疾病亚组和未来试验四个主题组。

主要发现

  • 20条声明中14条获一致共识,其余6条一致性超过90%。
  • GCIG各组成员积极审议后的高接受率证实共识流程可在虚拟环境下应用。

关键数值与推荐

  • 20条共识声明中14条获一致共识,其余6条一致性超过90%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research was held virtually in October, 2021, following published consensus guidelines. The goal of the consensus meeting was to achieve harmonisation on the design elements of upcoming trials in ovarian cancer, to select important questions for future study, and to identify unmet needs. All 33 GCIG member groups participated in the development, refinement, and adoption of 20 statements within four topic groups on clinical research in ovarian cancer including first line treatment, recurrent disease, disease subgroups, and future trials. Unanimous consensus was obtained for 14 of 20 statements, with greater than 90% concordance in the remaining six statements. The high acceptance rate following active deliberation among the GCIG groups confirmed that a consensus process could be applied in a virtual setting. Together with detailed categorisation of unmet needs, these consensus statements will promote the harmonisation of international clinical research in ovarian cancer.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Vergote I, Gonzalez-Martin A, Lorusso D, et al. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Lancet Oncol. 2022. PMID: 35901833. doi:10.1016/S1470-2045(22)00139-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。